These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 12852825)

  • 21. Nuclear receptors, transcription factors linking lipid metabolism and immunity: the case of peroxisome proliferator-activated receptor gamma.
    Varga T; Nagy L
    Eur J Clin Invest; 2008 Oct; 38(10):695-707. PubMed ID: 18837794
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Teaching resources. Nuclear receptors.
    Taneja R
    Sci STKE; 2005 May; 2005(286):tr17. PubMed ID: 15928334
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuronal differentiation of embryonic midbrain cells by upregulation of peroxisome proliferator-activated receptor-gamma via the JNK-dependent pathway.
    Park KS; Lee RD; Kang SK; Han SY; Park KL; Yang KH; Song YS; Park HJ; Lee YM; Yun YP; Oh KW; Kim DJ; Yun YW; Hwang SJ; Lee SE; Hong JT
    Exp Cell Res; 2004 Jul; 297(2):424-33. PubMed ID: 15212945
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peroxisome proliferator-activated receptor-gamma activator 15-deoxy-Delta12,14-prostaglandin J2 inhibits neuroblastoma cell growth through induction of apoptosis: association with extracellular signal-regulated kinase signal pathway.
    Kim EJ; Park KS; Chung SY; Sheen YY; Moon DC; Song YS; Kim KS; Song S; Yun YP; Lee MK; Oh KW; Yoon DY; Hong JT
    J Pharmacol Exp Ther; 2003 Nov; 307(2):505-17. PubMed ID: 12966153
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disruption of transforming growth factor beta signaling and profibrotic responses in normal skin fibroblasts by peroxisome proliferator-activated receptor gamma.
    Ghosh AK; Bhattacharyya S; Lakos G; Chen SJ; Mori Y; Varga J
    Arthritis Rheum; 2004 Apr; 50(4):1305-18. PubMed ID: 15077315
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activation of mitogen-activated protein kinases by peroxisome proliferator-activated receptor ligands: an example of nongenomic signaling.
    Gardner OS; Dewar BJ; Graves LM
    Mol Pharmacol; 2005 Oct; 68(4):933-41. PubMed ID: 16020742
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Peroxisome proliferator-activated receptors and atherosclerosis].
    Jin N; Wang X
    Sheng Li Ke Xue Jin Zhan; 2004 Jan; 35(1):13-8. PubMed ID: 15127591
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased cortical cell loss and prolonged hemodynamic depression after traumatic brain injury in mice lacking the IP receptor for prostacyclin.
    Lundblad C; Grände PO; Bentzer P
    J Cereb Blood Flow Metab; 2008 Feb; 28(2):367-76. PubMed ID: 17713464
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cell cross-talk mediates PPARalpha null hepatocyte proliferation after peroxisome proliferator exposure.
    Weglarz TC; Sandgren EP
    Carcinogenesis; 2004 Jan; 25(1):107-12. PubMed ID: 14514660
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Activation of transcriptional factor by signal transduction: overview].
    Kato S
    Tanpakushitsu Kakusan Koso; 2000 Jun; 45(9 Suppl):1523-5. PubMed ID: 10879129
    [No Abstract]   [Full Text] [Related]  

  • 31. Peroxisome proliferator-activated receptor-delta attenuates colon carcinogenesis.
    Harman FS; Nicol CJ; Marin HE; Ward JM; Gonzalez FJ; Peters JM
    Nat Med; 2004 May; 10(5):481-3. PubMed ID: 15048110
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Different modulation of ER-mediated transactivation by xenobiotic nuclear receptors depending on the estrogen response elements and estrogen target cell types.
    Min G
    Ann N Y Acad Sci; 2006 Dec; 1091():244-57. PubMed ID: 17341619
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Subcellular trafficking signals of constitutive androstane receptor: evidence for a nuclear export signal in the DNA-binding domain.
    Xia J; Kemper B
    Drug Metab Dispos; 2007 Sep; 35(9):1489-94. PubMed ID: 17567731
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peroxisome proliferator-activated receptor gamma in diabetes and metabolism.
    Rangwala SM; Lazar MA
    Trends Pharmacol Sci; 2004 Jun; 25(6):331-6. PubMed ID: 15165749
    [TBL] [Abstract][Full Text] [Related]  

  • 35. From molecular action to physiological outputs: peroxisome proliferator-activated receptors are nuclear receptors at the crossroads of key cellular functions.
    Feige JN; Gelman L; Michalik L; Desvergne B; Wahli W
    Prog Lipid Res; 2006 Mar; 45(2):120-59. PubMed ID: 16476485
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diminished hepatocellular proliferation in mice humanized for the nuclear receptor peroxisome proliferator-activated receptor alpha.
    Cheung C; Akiyama TE; Ward JM; Nicol CJ; Feigenbaum L; Vinson C; Gonzalez FJ
    Cancer Res; 2004 Jun; 64(11):3849-54. PubMed ID: 15172993
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peroxisome proliferator-activated receptor and farnesoid X receptor ligands differentially regulate sebaceous differentiation in human sebaceous gland organ cultures in vitro.
    Downie MM; Sanders DA; Maier LM; Stock DM; Kealey T
    Br J Dermatol; 2004 Oct; 151(4):766-75. PubMed ID: 15491415
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Angiogenic effect of prostaglandin I 2 in relation with its effect on PPAR nuclear receptors.
    Kubis N; Levy BI
    J Mol Cell Cardiol; 2004 Mar; 36(3):331-2. PubMed ID: 15010271
    [No Abstract]   [Full Text] [Related]  

  • 39. Activation of peroxisome proliferator-activated receptor-gamma inhibits differentiation of preosteoblasts.
    Khan E; Abu-Amer Y
    J Lab Clin Med; 2003 Jul; 142(1):29-34. PubMed ID: 12878983
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Focus on prostacyclin and its novel mimetics.
    Wise H; Jones RL
    Trends Pharmacol Sci; 1996 Jan; 17(1):17-21. PubMed ID: 8789354
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.